Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar henncoop (96.77) Submitted: 5/16/2007 1:30:17 PM : Outperform Start Price: $6.20 VRX Score: +689.65

near 52 week low

Featured Broker Partners


Advertisement